Australian Clinical Labs Limited (ACL.XA)

3.0100 -0.0600 (-1.95%) At close: 03:59PM AEDT

Australian Clinical Labs Limited

1868-1892 Dandenong Road
Clayton, VIC 3168
Australia
61 3 9538 6777
https://www.clinicallabs.com.au

Sector(s): 
Industry: 
Full Time Employees: 5,400

Key Executives

Name	Title	Pay	Exercised	Year Born
Ms. Melinda McGrath	CEO & Exec. Director	1.81M	N/A	N/A
Mr. James Davison	Chief Financial Officer	936.09k	N/A	N/A
Mr. Anthony Friedli	Chief Operating Officer	N/A	N/A	N/A
Mr. Sean Jackson	Chief Information Officer	N/A	N/A	N/A
Mr. Joe Geran	National Marketing Director	N/A	N/A	N/A
Associate Prof. Tony Landgren	National Medical Director & Chief Pathologist	N/A	N/A	N/A
Mr. Chris Brownlow	Chief Exec. Officer of New South Wales & Australian Capital Territory	N/A	N/A	N/A
Ms. Shae Seymour	Chief Exec. Officer of Western Australia	N/A	N/A	N/A
Mr. Eric Swayn	Chief Exec. Officer of South Australia & Northern Territory	N/A	N/A	N/A
Ms. Eleanor Padman B.A., FCIS	Company Sec.	N/A	N/A	N/A

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Australian Clinical Labs Limited provides pathology services in Australia. The company offers range of services, which include routine pathology test, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology, and cytopathology; hematology, allergy, and immunology; serology and microbiology; and infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing services. It offers its service to private and public hospitals. The company was incorporated in 2020 and is headquartered in Clayton, Australia.

Corporate Governance

Australian Clinical Labs Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.